KSS

Kohl's Reports Fourth Quarter and Full Year Fiscal 2022 Financial Results

Retrieved on: 
Wednesday, March 1, 2023
Men, Other Retail, Online Retail, Family, Discount, Variety, Department Stores, Specialty, Consumer, Fashion, Retail, Other Consumer, Women, Footwear, SG, NYSE, Operating cost, Partnership, Part, Sephora, General Administration of Press and Publication, KSS, Capital expenditure, Video game, Reinsurance, Music

Kohl’s Corporation (NYSE:KSS) today reported results for the quarter and year ended January 28, 2023.

Key Points: 
  • Kohl’s Corporation (NYSE:KSS) today reported results for the quarter and year ended January 28, 2023.
  • Tom Kingsbury, Kohl’s chief executive officer, stated, “Kohl’s fourth quarter results reflect meaningful proactive measures we took to better position the business for 2023, as well as sales pressure driven by the ongoing persistent inflationary environment.
  • Clearance markdowns impacted margin by approximately 750 basis points and product cost inflation impacted margin by approximately 200 bps.
  • Operating cash flow was $707 million driven by improvements in working capital during the fourth quarter of 2022.

Kleos Space Joins Ursa Space Virtual Constellation, Accelerates Tip & Cue Capabilities

Retrieved on: 
Tuesday, February 28, 2023
Constellation, Kleos Space, Kleos, Data, RF, Intelligence, ASX, Database, KSS, SAR, Ursa, Behavior, Defence Analytical Services and Advice, Cue, ISR, Communications satellite, Retail

Kleos intelligence products are available now to provide valuable intelligence, surveillance, and reconnaissance (ISR) capability to governments and commercial entities.

Key Points: 
  • Kleos intelligence products are available now to provide valuable intelligence, surveillance, and reconnaissance (ISR) capability to governments and commercial entities.
  • Under the agreement, Ursa will have access to the LOCATE intelligence product, which enhances Ursa Space's analytics platform in diversifying correlatable data.
  • Ursa Space holds the world's largest Virtual Constellation of satellite imagery and data fusion capabilities from the most trusted SAR, optical, and RF data vendors around the globe.
  • "The addition of the Kleos Space LOCATE product will accelerate our Tip and Cue capabilities by adding a key layer to our data fusion process," said Eric Cote, Director of Data & Analytic Services at Ursa Space.

Kohl's Names Dave Alves President & Chief Operating Officer

Retrieved on: 
Tuesday, February 28, 2023
Fashion, Online Retail, Retail, Jewelry, Department Stores, Home Goods, NYSE, Bay, KSS, TJX Companies, Canada, TJX, Risk management, Bealls

Kohl's (NYSE: KSS) today announced that 30-year retail veteran Dave Alves has been named Kohl's President & Chief Operating Officer, reporting to CEO Tom Kingsbury, effective in April.

Key Points: 
  • Kohl's (NYSE: KSS) today announced that 30-year retail veteran Dave Alves has been named Kohl's President & Chief Operating Officer, reporting to CEO Tom Kingsbury, effective in April.
  • "We are thrilled to have Dave join our senior leadership team as we drive the business forward," said Kingsbury.
  • Most recently, Alves was president and chief retail officer for Bealls Retail Group, overseeing all Bealls Stores, Bealls Outlet Stores, Burkes Outlet Stores, and Home Centric.
  • Prior to Bealls, Alves held leadership roles at TJX Canada and TJX Europe, Hudson's Bay and Sterling Shoes.

Kohl’s Declares Quarterly Dividend

Retrieved on: 
Wednesday, February 22, 2023
Cosmetics, Retail, Department Stores, Fashion, NYSE, KSS, Holding company

On February 21, 2023, the Board of Directors of Kohl’s Corporation (NYSE:KSS) declared a regular quarterly dividend of $0.50 per share on the Company’s common stock. The dividend is payable March 29, 2023, to shareholders of record at the close of business on March 15, 2023.

Key Points: 

On February 21, 2023, the Board of Directors of Kohl’s Corporation (NYSE:KSS) declared a regular quarterly dividend of $0.50 per share on the Company’s common stock. The dividend is payable March 29, 2023, to shareholders of record at the close of business on March 15, 2023.

Kohl's Names Nick Jones Chief Merchandising and Digital Officer

Retrieved on: 
Thursday, February 9, 2023
Online Retail, Fashion, Discount, Variety, Retail, Department Stores, Chief digital officer, Marks & Spencer, United Kingdom, Chief merchandising officer, Kohl's, NYSE, KSS, Marks, Walmart, Nordstrom, Digital, George, Department store, Beauty, Dillards

Kohl's (NYSE: KSS) today announced that 25-year retail veteran Nick Jones has been named Kohl's Chief Merchandising and Digital Officer, reporting directly to CEO Tom Kingsbury, effective in March.

Key Points: 
  • Kohl's (NYSE: KSS) today announced that 25-year retail veteran Nick Jones has been named Kohl's Chief Merchandising and Digital Officer, reporting directly to CEO Tom Kingsbury, effective in March.
  • In this role, Jones will be responsible for Kohl's overall merchandise strategy and all merchandising functions including buying, digital and omnichannel merchandising, product design and development, and product portfolio strategy.
  • "Nick has a tremendous wealth of experience in merchandising, retail, global sourcing, and business leadership.
  • Jones has more than 25 years of merchandising, brand, retail, and leadership experience, including working with the senior leadership team at Walmart.

Kohl's Announces $750,000 Donation to Hunger Task Force to Reduce Food Insecurity in Milwaukee

Retrieved on: 
Wednesday, February 8, 2023
Fashion, Philanthropy, Retail, Department Stores, Other Philanthropy, Fund Raising, Foundation, FoodShare Toronto, Organization, The Farm, Kohl's, Hunger Task Force, Inc., NYSE, Table, Poverty, KSS, Food, Meal, Child, Partnership, Part, Volunteering, COVID, Farm, Hunger, Agriculture, Management, Milwaukee metropolitan area

Kohl’s (NYSE: KSS) announced today a $750,000 donation to Hunger Task Force to further the organization’s mission of ensuring everyone in the Milwaukee community has access to nutritious food at no cost.

Key Points: 
  • Kohl’s (NYSE: KSS) announced today a $750,000 donation to Hunger Task Force to further the organization’s mission of ensuring everyone in the Milwaukee community has access to nutritious food at no cost.
  • As Milwaukee’s free and local food bank, Hunger Task Force feeds nearly 75,000 people in their food pantries, homeless shelters, and senior dining sites, and serves 35,000 meals in soup kitchens each month.
  • The $750,000 donation from Kohl’s builds on the company’s long-standing commitment to supporting the work Hunger Task Force is doing to reduce food insecurity in Milwaukee.
  • In 2022 alone, thanks to the support of Kohl’s, Hunger Task Force was able to:
    Distribute 9.5 million pounds of nutritious emergency food to its network of food pantries and meal programs.

Kohl’s Appoints Tom Kingsbury as Chief Executive Officer

Retrieved on: 
Thursday, February 2, 2023
Fashion, Footwear, Online Retail, Retail, Catalog, Home Goods, Interim, NYSE, KSS, Management

Kohl’s Corporation ("Kohl’s" or the "Company") (NYSE: KSS) announced today its Board of Directors (“Board”) has unanimously appointed Tom Kingsbury as Chief Executive Officer, effective as of February 2, 2023.

Key Points: 
  • Kohl’s Corporation ("Kohl’s" or the "Company") (NYSE: KSS) announced today its Board of Directors (“Board”) has unanimously appointed Tom Kingsbury as Chief Executive Officer, effective as of February 2, 2023.
  • Mr. Kingsbury has served as Interim Chief Executive Officer since December 2, 2022.
  • Mr. Kingsbury will continue to serve on the Company's Board.
  • “This is a pivotal time for Kohl’s, and I am excited and energized to work with our talented team to elevate our performance and create value,” said Kingsbury.

Wee-Cig International Corp. Signs Definitive Agreement to Acquire Controlling Interest in The Jamaican Brew House

Retrieved on: 
Monday, February 6, 2023
Marketing, Economics, Cannabis, Mining, Corporation, Acquisition, KSS, Bias, Nobility, University Ramon Llull, FMB, House, Cayman Islands, Patent, Multinational corporation, Brew House Association, Food, Commerce, Growth, Coffee, Management

With this acquisition, management is eager to enter the cannabis industry with such a strong and innovative partner.

Key Points: 
  • With this acquisition, management is eager to enter the cannabis industry with such a strong and innovative partner.
  • The Jamaican Brew House team, including leaders in sales, marketing, food processing and corporate advisory bring their deep industry knowledge to our operations.
  • "We are excited to announce entry into a definitive agreement to acquire a controlling interest in The Jamaican Brew House,” said Efraim Babayov, President of Wee-Cig International Corporation.
  • “Kickstarting commercial sales for The Jamaican Brew House products is expected to be the focus of Wee-Cig in 2023.

Minovia Therapeutics Reports First Clinical Data Demonstrating Disease-Modifying Efficacy and Safety of Mitochondrial Augmentation Therapy in Pediatric Patients with Primary Mitochondrial Diseases

Retrieved on: 
Wednesday, December 21, 2022
Immunodeficiency, Blood, Food, Therapy, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Failure, Quality of life, Pearson syndrome, DNA, Mitochondrion, Trial of the century, HSPC, Disease, Sheba Medical Center, KSS, MAT, Patient, Health, Weight gain, Microdeletion syndrome, Tel HaShomer, A-DNA, Safety, Science Translational Medicine, Sideroblastic anemia, Pearson, Hematology, Stem cell, Vaccine, Pharmaceutical industry, Medical imaging

WOBURN, Mass. and HAIFA, Israel, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Minovia Therapeutics, a clinical-stage global biotechnology company, today announced that the findings of the first clinical use of mitochondrial augmentation therapy (MAT) platform to treat pediatric patients with primary mitochondrial diseases have been published in Science Translational Medicine. The study was conducted in collaboration with global leaders in the field of hematology and primary mitochondrial disease at Sheba Medical Center (Tel Hashomer, Israel).

Key Points: 
  • and HAIFA, Israel, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Minovia Therapeutics, a clinical-stage global biotechnology company, today announced that the findings of the first clinical use of mitochondrial augmentation therapy (MAT) platform to treat pediatric patients with primary mitochondrial diseases have been published in Science Translational Medicine.
  • Single, large deletions in mitochondrial DNA (mtDNA) can lead to a variety of devastating diseases, including Pearson Syndrome and Kearns-Sayre Syndrome (KSS).
  • Minovia is developing MAT to treat Primary Mitochondrial Diseases such as Pearson syndrome, as well as other mitochondrially-related sideroblastic anemias.
  • "We believe these findings lay important groundwork for further development of MAT and future clinical trials to demonstrate the effectiveness and safety of MAT in patients with primary mitochondrial disorders and other diseases.